MHRA News
-
Medical
Device Alert: LIFEPAK 20/20e defibrillator/monitor,
manufactured by Medtronic/Physio-Control
(MDA/2010/070)
This Medical Device Alert has been issued due to
component failures, which affect AC (mains) and/or DC
(battery) operating power, there is a risk that the
defibrillator will not deliver therapy.
-
Fees
for medicines: Reminder to cancel licences by the end
of December 2010
Holders of authorisations, registrations and
licences are required to notify the MHRA by 31 December
2010 to cancel authorisations, registrations and
licences from 31 March 2011.
-
Press
release: Suspended sentence for the illegal sale and
supply of sex drugs
A 61-year-old man from Sutton Coldfield, West
Midlands, received a nine-month prison sentence
suspended for two years yesterday (Monday 6 September),
with supervision for one year, at Birmingham Crown
Court for the illegal sale and supply of erectile
dysfunction medicines.
-
Medical
Device Alert: ASR™ hip replacement implants
manufactured by DePuy International Ltd
(MDA/2010/069)
This Medical Device Alert has been issued because
the manufacturer, DuPuy International Ltd, has recalled
ASR™ hip replacement implants due to increased
rates of revision.
-
Medical
Device Alert: IV extension sets with multiple ports
and vented caps. Various manufacturers
(MDA/2010/068)
This Medical Device Alert has been issued as an
incident has been reported where a patient suffered a
stroke when an IV extension set, which had a vented cap
attached to its Y-port, was connected to a central
line.
-
Current
advice and information about the use of rosiglitazone
(Avandia, Avandamet▼) in the treatment of
diabetes
The MHRA is contributing to the ongoing Europe wide
review of rosiglitazone.
-
Information
sent to healthcare professionals in August about the
safety of medicines
A list of letters sent to healthcare professionals
in August 2010, to inform of new safety information and
advice.
-
Press
release: PIP (Poly Implant Prosthese) breast implants
– UK test results
We have received encouraging results of UK testing
on the silicone gel breast implants manufactured by the
French company Poly Implant Prosthese (PIP). The tests
found no evidence of genotoxicity (potential for
cancer) or chemical toxicity of the filler material in
the implants.
|
|
|